An environmental risk assessment of eleven pharmaceuticals according to the guideline
recommended by the European Medicines Evaluation Agency (EMEA) was performed …

An environmental risk assessment is presented for the 25 most used pharmaceuticals in the
primary health sector in Denmark. Predicted environmental concentrations (PECs) for the …

In this study, exposure and ecotoxicity data of six human pharmaceuticals (carbamazepine,
clofibric acid, diclofenac, ofloxacin, propranolol, and sulfamethoxazole) were collected …

Since 1993, an environmental risk assessment (ERA) for a new drug application has been
stipulated by EU Directive 93/39/EEC amending Directive 65/65/EEC. In early 2001, after …

The Swedish environmental and classification system for pharmaceuticals is a voluntary,
industry-owned system with the purpose to provide environmental information about active …

Presented here, based on new recommendations of the European Commission, is an
environmental risk assessment (ERA) of a selected group of pharmaceuticals for Phase I …

The pharmaceuticals and pharmaceutical metabolites salicylic acid, paracetamol, clofibrinic
acid, and methotrexate were examined with regard to their biological degradability and …

For many older pharmaceuticals, chronic aquatic toxicity data are limited. To assess risk
during development, scale‐up, and manufacturing processes, acute data and …

This paper presents 10 recommendations for improving the European Medicines Agency's
guidance for environmental risk assessment of human pharmaceutical products. The …

The potential risks associated with antibiotics present in the Swedish environment were
assessed using concentrations found in hospital effluent, and sewage treatment waters and …